Doctors Found a Blood Type Hiding in Plain Sight Since 1972

Keypoints:

• Scientists confirmed the genetic cause behind the rare AnWj blood antigen, establishing a new blood group system called MAL
• The mystery dates back to a 1972 blood sample from a pregnant woman
• More than 99.9% of people carry the AnWj antigen; only a handful of AnWj-negative people had ever been identified
• Researchers spent nearly 20 years tracing the antigen to the MAL gene
• The discovery enables new genetic tests to protect rare patients from dangerous transfusion reactions

In 1972, a routine blood test on a pregnant woman turned up something doctors couldn't explain: her red blood cells were missing a marker found on almost everyone else's. That marker, called AnWj, sat unsolved for more than 50 years until researchers at NHS Blood and Transplant and the University of Bristol finally traced its genetic origin, establishing a brand-new blood group system called MAL.

More than 99.9% of people carry the AnWj antigen. The tiny fraction who don't face a real risk if they ever receive standard blood, a potentially dangerous transfusion reaction, and until now, doctors had no reliable way to identify them in advance. 

Hematologist Louise Tilley and cell biologist Tim Satchwell spent close to two decades chasing the cause, eventually finding that AnWj-negative individuals carry deletions in both copies of a gene called MAL.

To confirm the link, researchers inserted a normal copy of the MAL gene into AnWj-negative blood cells grown in the lab. The antigen appeared right on cue. Mutated versions of the gene failed to produce it at all, closing the loop on a connection scientists had chased since the Nixon administration.

The payoff is practical, not just academic. Genetic screening built on this discovery can now flag AnWj-negative patients before a transfusion goes wrong, rather than doctors discovering the mismatch during an actual medical emergency. 

It's also a reminder that human biology still holds basic gaps textbooks haven't filled in, more than 50 years after the first clue showed up in a single patient's blood sample.